Tandem Diabetes Care (Nasdaq:TNDM) shares took a hit after hours today on fourth-quarter results that topped the consensus ...

Senseonics announced today that it integrated SweetSpot software with its Eversense 365 continuous glucose monitor (CGM) in ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

Abbott (NYSE:ABT) announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on ...

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses. In 2024, the FDA approved a nasal spray as the first at-home influenza ...

A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom ...

For 2025, Insulet expects revenue growth between 16% and 20%. It projects Omnipod sales to increase by 17%-21%.

Blue Cross Blue Shield of Massachusetts announced that it expanded its care options for members with diabetes.